• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of countermeasures and prognostic markers for sarcopenia associated with nonalcoholic steatohepatitis

Research Project

Project/Area Number 21K15953
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionKumamoto University

Principal Investigator

Setoyama Hiroko  熊本大学, 病院, 助教 (90796103)

Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2023: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2022: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2021: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywordsサルコペニア / 非アルコール性脂肪肝炎 / 酸化ストレス / タンパク質過酸化物 / 還元型アルブミン / マイオカイン / NASH/NAFLD
Outline of Research at the Start

酸化ストレスが発症要因の1つと考えられているサルコペニアは、非アルコール性脂肪性肝疾患(NAFLD)の発症、肝線維化の進展や合併症の発症に関与しており、その予防は非アルコール性脂肪肝炎 (NASH)の重要な治療である。本研究ではNAFLD/NASH患者において、抗酸化に重要な役割を果たしている還元型・ 酸化型アルブミン(ヒト血清アルブミンの翻訳後修飾体)のモニタリングを行い、体組成や筋力との関連を明らかにすることを目的とする。さらにその結果に基づき、サルコペニアの治療効果や予後予測に関するバイオマーカーを見いだすことで、酸化ストレス制御を介した治療を確立することが最終目標である。

Outline of Final Research Achievements

The association of reduced and oxidized albumin (HMA) and advanced oxidation protein products (AOPPs) levels with the clinical presentation of patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) was investigated in a total of 87 patients throughout the study period. Correlation analysis of factors related to muscle strength and body composition (grip strength, muscle mass, body fat percentage, and muscle mass) revealed that grip strength demonstrated a strong correlation with HMA mass, while L3-level muscle mass exhibited a strong correlation with AOPPs and a moderate correlation with HMA mass (r=0.523). In the study of animal experimental models, NASH was evaluated in choline-deficient, high-fat diet (ChD-HFD) mice. The same evaluation was also performed on mice created by administering a high-fat diet to aged mice for 8 weeks as a NASH+sarcopenia model. Grip strength exhibited a tendency to be lower in the latter.

Academic Significance and Societal Importance of the Research Achievements

我々の検討によりAOPPsや還元型アルブミンがMASLD/MASH患者に関連したサルコペニア予備軍の早期診断に有用なバイオマーカーであることが示唆された。MASLD/MASH患者では、健常人と比較してサルコペニアの合併率が有意に高い。またサルコペニアはそれ自体がMASLDのリスク因子であるだけでなく、MASHや肝線維化進展に関与する因子であることや肝硬変患者の死亡リスクを約2倍高めることなどが明らかになっており、MASH関連サルコペニアにおける早期診断マーカーや治療法の開発が求められている。今後はこれらがサルコペニアに関与するメカニズムについて検討が必要である。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (28 results)

All 2024 2023 2022 2021

All Journal Article (17 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 16 results,  Open Access: 5 results) Presentation (9 results) (of which Int'l Joint Research: 2 results) Book (2 results)

  • [Journal Article] Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase2024

    • Author(s)
      Nagaoka Katsuya、Bai Xuewei、Liu Dan、Cao Kevin、Mulla Joud、Ji Chengcheng、Chen Hongze、Nisar Muhammad Azhar、Bay Amalia、Mueller William、Hildebrand Grace、Gao Jin-Song、Lu Shaolei、Setoyama Hiroko、Tanaka Yasuhito、Wands Jack R.、Huang Chiung-Kuei
    • Journal Title

      Cancer Letters

      Volume: 580 Pages: 216493-216493

    • DOI

      10.1016/j.canlet.2023.216493

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Role of Regional Core Centers for Liver Disease Management in the Continuity of Activities of Hepatitis Medical Care Coordinators2023

    • Author(s)
      Setoyama Hiroko、Nomura Maki、Yada Tomomi、Yoshimaru Yoko、Narahara Satoshi、Inada Hiroki、Tanaka Kentaro、Kurano Sotaro、Tokunaga Takayuki、Iio Etsuko、Nagaoka Katsuya、Watanabe Takehisa、Eguchi Yuichiro、Tanaka Yasuhito
    • Journal Title

      Kanzo

      Volume: 64 Issue: 11 Pages: 583-586

    • DOI

      10.2957/kanzo.64.583

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2023-11-01
    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Which nonhepatology departments are in urgent need of measures for treating patients positive for hepatitis virus?2023

    • Author(s)
      Hirota Kenichi、Inoue Takako、Ogawa Koji、Arao Yoshihisa、Endo Mizuki、Ikegami Tadashi、Tojima Hiroki、Suetsugu Atsushi、Kakizaki Satoru、Setoyama Hiroko、Enomoto Masaru、Korenaga Masaaki
    • Journal Title

      Kanzo

      Volume: 64 Issue: 11 Pages: 587-589

    • DOI

      10.2957/kanzo.64.587

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2023-11-01
    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Present status of hepatitis medical care coordinators in regional core centers for liver disease management in Japan (second report)2023

    • Author(s)
      Isoda Hiroshi、Enomoto Masaru、Takahashi Hirokazu、Oono Takashi、Inoue Taisuke、Ikegami Tadashi、Ide Tatsuya、Tokumoto Yoshio、Ogawa Koji、Setoyama Hiroko et al.
    • Journal Title

      Kanzo

      Volume: 64 Issue: 10 Pages: 510-513

    • DOI

      10.2957/kanzo.64.510

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2023-10-01
    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Two cases of acute liver failure complicated by COVID-19 remarkably responded to anticoagulant therapy2023

    • Author(s)
      Oobo Hiromitsu、Inada Hiroki、Setoyama Hiroko、Narahara Satoshi、Tanaka Kentaro、Kurano Soutaro、Tokunaga Takayuki、Iio Etsuko、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Tanaka Motohiko、Tateyama Masakuni、Tanaka Yasuhito
    • Journal Title

      Kanzo

      Volume: 64 Issue: 6 Pages: 270-279

    • DOI

      10.2957/kanzo.64.270

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2023-06-01
    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma2023

    • Author(s)
      Yoshimaru Yoko、Nagaoka Katsuya、Tanaka Kentaro、Narahara Satoshi、Inada Hiroki、Kurano Sotaro、Tokunaga Takayuki、Iio Etsuko、Watanabe Takehisa、Setoyama Hiroko、Tateyama Masakuni、Yoshida Koji、Tsunoda Takuya、Nakamura Yusuke、Tanaka Motohiko、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      Hepatology Research

      Volume: - Issue: 5 Pages: 451-464

    • DOI

      10.1111/hepr.13995

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Dried blood spot-based host genome analysis technique targeting pathological associations with hepatitis B: Development and clinical application in the Cambodian population.2023

    • Author(s)
      Setoyama H, Yamazoe T, Kanto T et al.
    • Journal Title

      Hepatol Res

      Volume: 12 Issue: 12 Pages: 1147-1155

    • DOI

      10.1111/hepr.13949

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan2023

    • Author(s)
      Shimakami Tetsuro、Setoyama Hiroko、Oza Noriko、Itakura Jun、Kaneko Shun、Korenaga Masaaki、Toyama Tadashi、Tanaka Junko、Kanto Tatsuya
    • Journal Title

      Journal of Gastroenterology

      Volume: 58 Issue: 3 Pages: 257-267

    • DOI

      10.1007/s00535-023-01956-1

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma2023

    • Author(s)
      Tokunaga Takayuki、Tateyama Masakuni、Kondo Yasuteru、Miuma Satoshi、Miyase Shiho、Tanaka Kentaro、Narahara Satoshi、Inada Hiroki、Kurano Sotaro、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Setoyama Hiroko、Fukubayashi Kotaro、Tanaka Motohiko、Tanaka Yasuhito
    • Journal Title

      Cancers

      Volume: 15 Issue: 5 Pages: 1568-1568

    • DOI

      10.3390/cancers15051568

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study2022

    • Author(s)
      Matsuno Kenshi、Miyamoto Hideaki、Kitada Hideki、Yoshimatsu Shinichi、Tamura Fumio、Sakurai Kouichi、Fukubayashi Kotaro、Shono Takashi、Setoyama Hiroko、Matsuyama Taichi、Suko Shinichiro、Narita Rei、Honda Munenori、Tateyama Masakuni、Naoe Hideaki、Morinaga Jun、Tanaka Yasuhito、Gushima Ryosuke
    • Journal Title

      DEN Open

      Volume: 3 Issue: 1

    • DOI

      10.1002/deo2.163

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity.2022

    • Author(s)
      Tokunaga T, Nagaoka K, Watanabe T, Tanaka M, Tanaka Y, et al.
    • Journal Title

      Hepatol Res

      Volume: 52 Issue: 1 Pages: 105-119

    • DOI

      10.1111/hepr.13720

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Seamless support from screening to anti-HCV treatment and HCC/decompensated cirrhosis: Subsidy programs for HCV elimination2021

    • Author(s)
      Setoyama Hiroko、Tanaka Yasuhito、Kanto Tatsuya
    • Journal Title

      Global Health & Medicine

      Volume: 3 Issue: 5 Pages: 335-342

    • DOI

      10.35772/ghm.2021.01079

    • NAID

      130008114455

    • ISSN
      2434-9186, 2434-9194
    • Year and Date
      2021-10-31
    • Related Report
      2021 Research-status Report
    • Open Access
  • [Journal Article] A case of primary hepatic leiomyosarcoma treated with multi-line chemotherapy2021

    • Author(s)
      Narahara Satoshi、Nagaoka Katsuya、Tateyama Masakuni、Miyamoto Hideaki、Tanaka Kentaro、Tokunaga Takayuki、Kawasaki Takeshi、Yoshimaru Yoko、Watanabe Takehisa、Setoyama Hiroko、Naoe Hideaki、Tanaka Motohiko、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      Kanzo

      Volume: 62 Issue: 9 Pages: 538-547

    • DOI

      10.2957/kanzo.62.538

    • NAID

      130008086350

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2021-09-01
    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] HCV撲滅に向けた医療行政の整備2021

    • Author(s)
      Setoyama Hiroko、Kanto Tatsuya
    • Journal Title

      Kanzo

      Volume: 62 Issue: 4 Pages: 220-222

    • DOI

      10.2957/kanzo.62.220

    • NAID

      130008022231

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2021-04-01
    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Present status of hepatitis medical care coordinators in regional core centers in Japan2021

    • Author(s)
      Enomoto Masaru、Hidaka Isao、Inoue Taisuke、Isoda Hiroshi、Ide Tatsuya、Arao Yoshihisa、Uchida Yoshihito、Inoue Takako、Ikegami Tadashi、Kakizaki Satoru、Setoyama Hiroko、Shimakami Tetsuro、Ogawa Koji、Suetsugu Atsushi、Inoue Jun、Endo Mizuki、Nagata Kenji、Korenaga Masaaki
    • Journal Title

      Kanzo

      Volume: 62 Issue: 2 Pages: 96-98

    • DOI

      10.2957/kanzo.62.96

    • NAID

      130007981300

    • ISSN
      0451-4203, 1881-3593
    • Year and Date
      2021-02-01
    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma2021

    • Author(s)
      Narahara S, Watanabe T, Nagaoka K, Fujimoto N, Furuta Y, Tanaka K, Tokunaga T, Kawasaki T, Yoshimaru Y, Setoyama H, Oniki K, Saruwatari J, Tateyama M, Naoe H, Tanaka M, Tanaka Y, Sasaki Y.
    • Journal Title

      Hepatology Communications

      Volume: - Issue: 5 Pages: 1198-1212

    • DOI

      10.1002/hep4.1872

    • Related Report
      2022 Research-status Report 2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis2021

    • Author(s)
      Itakura Jun、Kurosaki Masayuki、Setoyama Hiroko、Simakami Tetsuro、Oza Noriko、Korenaga Masaaki、Tanaka Motohiko、Torimura Takuji、Sakamoto Naoya、Enomoto Nobuyuki、Ueno Yoshiyuki、Kawada Norifumi、Kaneko Shuichi、Nishiguchi Shuhei、Chayama Kazuaki、Tanaka Junko、Izumi Namiki、Kanto Tatsuya
    • Journal Title

      Journal of Gastroenterology

      Volume: 56 Issue: 5 Pages: 470-478

    • DOI

      10.1007/s00535-021-01782-3

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Nationwide survey of clinical indicators to assess quality of liver disease care in Japan.2024

    • Author(s)
      Hiroko Setoyama, Noriko Oza, Tetsuro Shimakami, Junko Tanakai, Yasuhito Tanaka, Tatsuya Kanto
    • Organizer
      APASL
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 肝疾患専門医療機関での肝炎ウイルス陽性者拾い上げ、肝がん・重度肝硬変医療費助成申請における多職種連携の在り方.2023

    • Author(s)
      瀬戸山博子、立山雅邦、田中靖人
    • Organizer
      第59回日本肝臓学会総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] Nationwide survey of the impact of COVID-19 on the clinical practice and care of patients with liver disease in Japan.2023

    • Author(s)
      Hiroko Setoyama, Noriko Oza, Tetsuro Shimakami, Junko Tanakai, Yasuhito Tanaka, Tatsuya Kanto
    • Organizer
      AASLD Liver Meeting
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 謝異常にともなう脂肪肝に関する啓発ツールと肝臓専門医受診システムとの連動によるハイリスク患者受診促進への取り組み2023

    • Author(s)
      瀬戸山博子、渡邊丈久、吉丸洋子、長岡克弥、田中靖人
    • Organizer
      第122回日本消化器病学会九州支部例会
    • Related Report
      2023 Annual Research Report
  • [Presentation] ハイリスク患者の肝臓専門医受診促進における Fib-4 index計算サイトと肝臓専門医受診システムとの連動の有用性2022

    • Author(s)
      瀬戸山博子、渡邊丈久、田中靖人
    • Organizer
      第108回消化器病学会総会
    • Related Report
      2022 Research-status Report
  • [Presentation] COVID-19影響下における 肝疾患診療連携拠点病院での肝疾患診療および拠点病院事業2022

    • Author(s)
      瀬戸山博子、考藤達哉
    • Organizer
      第58回日本肝臓学会総会
    • Related Report
      2022 Research-status Report
  • [Presentation] 医療指標からみた肝疾患診療連携拠点病院における肝炎医療の現状と課題2022

    • Author(s)
      瀬戸山博子、田中靖人、考藤達哉
    • Organizer
      第58回日本肝臓学会総会
    • Related Report
      2022 Research-status Report
  • [Presentation] 熊本県における肝がんのハイリスク患者地域、職域、院内での拾い上げ2021

    • Author(s)
      瀬戸山博子、立山雅邦、田中靖人
    • Organizer
      第107回日本消化器病学会総会
    • Related Report
      2021 Research-status Report
  • [Presentation] 肝疾患専門医療機関における院内肝炎ウイルス陽性者の専門医受診に関する実態調査2021

    • Author(s)
      瀬戸山 博子、米田暁、市川亮、佐々木雅人、是永匡紹
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Research-status Report
  • [Book] 消化器内科 第20号(Vol.3 No.7,2021)2021

    • Author(s)
      瀬戸山博子、考藤達哉
    • Total Pages
      96
    • Publisher
      医学出版
    • Related Report
      2021 Research-status Report
  • [Book] Medical Science Digest 2021年 12月号2021

    • Author(s)
      瀬戸山博子、島上哲朗、考藤達哉
    • Total Pages
      54
    • Publisher
      ニュー・サイエンス社
    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi